<DOC>
	<DOCNO>NCT00042471</DOCNO>
	<brief_summary>This randomize , open-label , crossover study examine bioavailability pramlintide normal weight overweight subject type 1 type 2 diabetes mellitus use insulin .</brief_summary>
	<brief_title>Evaluation Bioavailability Pramlintide</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Pramlintide</mesh_term>
	<mesh_term>Islet Amyloid Polypeptide</mesh_term>
	<criteria>HbA1c value 612 % BMI &lt; = 27 kg/m2 BMI &gt; =30 &lt; = 45 kg/m2 Consistent insulin regimen 2 month prior screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>